Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michio Hongo

Showing results (21-30 of 239) with videos related to

Pageof 24
Sort By:
Journal of Gastroenterology|April 18, 2003
Epidemiology of reflux disease and CLE in East AsiaMichio Hongo, Tomotaka Shoji
Journal of Gastroenterology|July 8, 2010
Risk factors for relapse of erosive GERD during long-term maintenance treatment with proton pump inhibitor: a prospective multicenter study in JapanKazuma Fujimoto, Michio Hongo,
Internal Medicine (Tokyo, Japan)|February 8, 2011
Safety and efficacy of long-term maintenance therapy with oral dose of rabeprazole 10 mg once daily in Japanese patients with reflux esophagitisKazuma Fujimoto, Michio Hongo,
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 11, 2006
[The gastrointestinal motor function in irritable bowel syndrome (IBS)]Yasuhiro Sagami, Michio Hongo
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 4, 2004
[Non-erosive GERD]Michio Hongo, Daisaku Tamura
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|November 7, 2007
[Epidemiology of dyspepsia and its therapeutic approach. Clinical practice starts with good relationship with patients]Michio Hongo, Yuka Endo
The American Journal of Gastroenterology|March 22, 2012
Efficacy of twice-daily rabeprazole for reflux esophagitis patients refractory to standard once-daily administration of PPI: the Japan-based TWICE studyYoshikazu Kinoshita, Michio Hongo,
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 1, 2002
[GERD/reflux esophagitis]Michio Hongo, Daisaku Tamura
Journal of Gastroenterology and Hepatology|March 30, 2011
Visceral hypersensitivity in irritable bowel syndromeMotoyori Kanazawa, Michio Hongo, Shin Fukudo
Digestion|April 28, 2012
Response to gastroesophageal reflux disease therapy: assessment at 4 weeks predicts response/non-response at 8 weeksMotoyasu Kusano, Michio Hongo, Hiroto Miwa
Pageof 24

Showing results (21-30 of 239) with videos related to

Sort By:
Pageof 24
Journal of Gastroenterology|April 18, 2003
Epidemiology of reflux disease and CLE in East AsiaMichio Hongo, Tomotaka Shoji
Journal of Gastroenterology|July 8, 2010
Risk factors for relapse of erosive GERD during long-term maintenance treatment with proton pump inhibitor: a prospective multicenter study in JapanKazuma Fujimoto, Michio Hongo,
Internal Medicine (Tokyo, Japan)|February 8, 2011
Safety and efficacy of long-term maintenance therapy with oral dose of rabeprazole 10 mg once daily in Japanese patients with reflux esophagitisKazuma Fujimoto, Michio Hongo,
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 11, 2006
[The gastrointestinal motor function in irritable bowel syndrome (IBS)]Yasuhiro Sagami, Michio Hongo
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 4, 2004
[Non-erosive GERD]Michio Hongo, Daisaku Tamura
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|November 7, 2007
[Epidemiology of dyspepsia and its therapeutic approach. Clinical practice starts with good relationship with patients]Michio Hongo, Yuka Endo
The American Journal of Gastroenterology|March 22, 2012
Efficacy of twice-daily rabeprazole for reflux esophagitis patients refractory to standard once-daily administration of PPI: the Japan-based TWICE studyYoshikazu Kinoshita, Michio Hongo,
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 1, 2002
[GERD/reflux esophagitis]Michio Hongo, Daisaku Tamura
Journal of Gastroenterology and Hepatology|March 30, 2011
Visceral hypersensitivity in irritable bowel syndromeMotoyori Kanazawa, Michio Hongo, Shin Fukudo
Digestion|April 28, 2012
Response to gastroesophageal reflux disease therapy: assessment at 4 weeks predicts response/non-response at 8 weeksMotoyasu Kusano, Michio Hongo, Hiroto Miwa
Pageof 24